INTEGER HOLDINGS CORPORATION (ITGR) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-07-03..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-07-03..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-07-03..
Borrowing debt
Overview →Financial period ending 2026-07-03; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-07-03. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-07-03. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-07-03. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | 0.00 USD | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | 1.24B USD | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Total assets | 3.42B USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2026-07-03 | (m) | (m) | $0.00 | $1.24B | (m) | (m) | $3.42B | (m) |
| 2026-04-03 | (m) | (m) | $0.00 | $1.25B | (m) | (m) | $3.41B | (m) |
| 2025-12-31 | (m) | (m) | $0.00 | $1.19B | (m) | (m) | $3.41B | (m) |
| 2025-09-26 | (m) | (m) | $0.00 | $1.19B | (m) | (m) | $3.40B | (m) |
| 2025-06-27 | (m) | (m) | $0.00 | $1.20B | (m) | (m) | $3.37B | (m) |
| 2025-03-28 | (m) | (m) | $11.00K | $1.24B | (m) | (m) | $3.30B | (m) |
| 2024-12-31 | (m) | (m) | $10.00M | $980.15M | (m) | (m) | $3.08B | (m) |
| 2024-09-27 | (m) | (m) | $5.00M | $1.07B | (m) | (m) | $3.17B | (m) |
| 2024-06-28 | (m) | (m) | $0.00 | $1.12B | (m) | (m) | $3.13B | (m) |
| 2024-03-29 | (m) | (m) | $0.00 | $1.14B | (m) | (m) | $3.12B | (m) |
| 2023-12-31 | (m) | (m) | $0.00 | $959.92M | (m) | (m) | $2.94B | (m) |
| 2023-09-29 | (m) | (m) | $0.00 | $941.38M | (m) | (m) | $2.84B | (m) |
| 2023-06-30 | (m) | (m) | $5.00M | $980.40M | (m) | (m) | $2.86B | (m) |
| 2023-03-31 | (m) | (m) | $10.00M | $992.47M | (m) | (m) | $2.87B | (m) |
| 2022-12-31 | (m) | (m) | $18.19M | $907.07M | (m) | (m) | $2.79B | (m) |
| 2022-09-30 | (m) | (m) | $15.25M | $923.40M | (m) | (m) | $2.74B | (m) |
| 2022-07-01 | (m) | (m) | $15.25M | $931.89M | (m) | (m) | $2.76B | (m) |
| 2022-04-01 | (m) | (m) | $15.25M | $814.38M | (m) | (m) | $2.61B | (m) |
| 2021-12-31 | (m) | (m) | $15.25M | $812.88M | (m) | (m) | $2.58B | (m) |
| 2021-10-01 | (m) | (m) | $20.25M | $610.40M | (m) | (m) | $2.35B | (m) |
| 2021-07-02 | (m) | (m) | $37.50M | $631.20M | (m) | (m) | $2.36B | (m) |
| 2021-04-02 | (m) | (m) | $37.50M | $649.63M | (m) | (m) | $2.34B | (m) |
| 2020-12-31 | (m) | (m) | $37.50M | $693.76M | (m) | (m) | $2.37B | (m) |
| 2020-10-02 | (m) | (m) | $37.50M | $801.61M | (m) | (m) | $2.45B | (m) |
| 2020-07-03 | (m) | (m) | $37.50M | $930.38M | (m) | (m) | $2.52B | (m) |
| 2020-04-03 | (m) | (m) | $37.50M | $793.83M | (m) | (m) | $2.40B | (m) |
| 2019-12-31 | (m) | (m) | $37.50M | $777.27M | (m) | (m) | $2.35B | (m) |
| 2019-09-27 | (m) | (m) | $37.50M | $790.42M | (m) | (m) | $2.36B | (m) |
| 2019-06-28 | (m) | (m) | $37.50M | $825.44M | (m) | (m) | $2.37B | (m) |
| 2019-03-29 | (m) | (m) | $37.50M | $874.16M | (m) | (m) | $2.37B | (m) |
| 2018-12-28 | (m) | (m) | $37.50M | $888.01M | (m) | (m) | $2.33B | (m) |
| 2018-09-28 | (m) | (m) | $37.50M | $916.69M | (m) | (m) | $2.36B | (m) |
| 2018-06-29 | (m) | (m) | $35.16M | $1.50B | (m) | (m) | $2.81B | (m) |
| 2018-03-30 | (m) | (m) | $32.81M | $1.53B | (m) | (m) | $2.85B | (m) |
| 2017-12-29 | (m) | (m) | $30.47M | $1.58B | (m) | (m) | $2.85B | (m) |
| 2017-09-29 | (m) | (m) | $28.13M | $1.60B | (m) | (m) | $2.85B | (m) |
| 2017-06-30 | (m) | (m) | $25.78M | $1.64B | (m) | (m) | $2.84B | (m) |
| 2017-03-31 | (m) | (m) | $34.17M | $1.67B | (m) | (m) | $2.84B | (m) |
| 2016-12-30 | (m) | (m) | $31.34M | $1.70B | (m) | (m) | $2.83B | (m) |
| 2016-09-30 | (m) | (m) | $29.00M | $1.72B | (m) | (m) | $2.88B | (m) |
| 2016-07-01 | (m) | (m) | $29.00M | $1.73B | (m) | (m) | $2.90B | (m) |
| 2016-04-01 | (m) | (m) | $29.00M | $1.73B | (m) | (m) | $2.91B | (m) |
| 2016-01-01 | (m) | (m) | $29.00M | $1.69B | (m) | (m) | $2.98B | (m) |
| 2015-10-02 | (m) | (m) | $15.00M | $165.00M | (m) | (m) | $983.62M | (m) |
| 2015-07-03 | (m) | (m) | $13.75M | $168.75M | (m) | (m) | $966.13M | (m) |
| 2015-04-03 | (m) | (m) | $12.50M | $172.50M | (m) | (m) | $946.72M | (m) |
| 2015-01-02 | (m) | (m) | $11.25M | $176.25M | (m) | (m) | $956.01M | (m) |
| 2014-10-03 | (m) | (m) | (m) | $190.00M | (m) | (m) | $931.29M | (m) |
| 2014-07-04 | (m) | (m) | (m) | $192.50M | (m) | (m) | $911.77M | (m) |
| 2014-04-04 | (m) | (m) | (m) | $195.00M | (m) | (m) | $890.38M | (m) |
| 2014-01-03 | (m) | (m) | (m) | $197.50M | (m) | (m) | $890.70M | (m) |
| 2013-09-27 | (m) | (m) | (m) | $210.00M | (m) | (m) | $884.71M | (m) |
| 2013-06-28 | (m) | (m) | (m) | $237.00M | (m) | (m) | $897.28M | (m) |
| 2013-03-29 | (m) | (m) | (m) | $233.00M | (m) | (m) | $884.92M | (m) |
| 2012-12-28 | (m) | (m) | (m) | $225.41M | (m) | (m) | $889.88M | (m) |
| 2012-09-28 | (m) | (m) | (m) | $230.15M | (m) | (m) | $891.93M | (m) |
| 2012-06-29 | (m) | (m) | (m) | $233.37M | (m) | (m) | $885.79M | (m) |
| 2012-03-30 | (m) | (m) | (m) | $238.64M | (m) | (m) | $886.99M | (m) |
| 2011-12-30 | (m) | (m) | (m) | $235.95M | (m) | (m) | $881.35M | (m) |
| 2011-09-30 | (m) | (m) | (m) | $198.31M | (m) | (m) | $811.84M | (m) |
| 2011-07-01 | (m) | (m) | (m) | $205.70M | (m) | (m) | $819.92M | (m) |
| 2010-12-31 | (m) | (m) | (m) | $220.63M | (m) | (m) | $776.98M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |